Context Therapeutics (CNTX) Insider Trading & Ownership $1.63 -0.02 (-1.21%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Context Therapeutics (NASDAQ:CNTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.04%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$119,029.74Number OfInsiders Selling(Last 3 Years)0 Get CNTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Context Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CNTX Insider Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Context Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/21/2023Martin A LehrCEOBuy5,823$0.84$4,891.32 2/13/2023Martin A LehrCEOBuy5,606$0.87$4,877.22 2/6/2023Martin A LehrCEOBuy5,040$0.97$4,888.80 1/30/2023Martin A LehrCEOBuy7,027$0.70$4,918.90 1/23/2023Martin A LehrCEOBuy6,839$0.72$4,924.08 1/17/2023Martin A LehrCEOBuy6,783$0.74$5,019.42 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/16/2022Jennifer Lynn Minai-AzaryCFOBuy25,000$0.74$18,500.00 12/9/2022Alex C LevitInsiderBuy6,000$0.85$5,100.00 8/19/2022Martin A LehrCEOBuy13,000$1.85$24,050.00 12/16/2021Martin A LehrCEOBuy13,000$3.22$41,860.00 (Data available from 1/1/2013 forward) CNTX Insider Trading Activity - Frequently Asked Questions Who is on Context Therapeutics's Insider Roster? The list of insiders at Context Therapeutics includes Alex C Levit, Jennifer Lynn Minai-Azary, and Martin A Lehr. Learn more on insiders at CNTX. What percentage of Context Therapeutics stock is owned by insiders? 3.04% of Context Therapeutics stock is owned by insiders. Learn more on CNTX's insider holdings. Which Context Therapeutics insiders have been buying company stock? The following insiders have purchased CNTX shares in the last 24 months: Alex C Levit ($5,100.00), Jennifer Lynn Minai-Azary ($18,500.00), and Martin A Lehr ($29,519.74). How much insider buying is happening at Context Therapeutics? Insiders have purchased a total of 68,118 CNTX shares in the last 24 months for a total of $53,119.74 bought. Context Therapeutics Key ExecutivesMr. Martin A. Lehr (Age 40)Co-Founder, President, CEO & Director Compensation: $674.08kMs. Jennifer Minai-Azary (Age 46)CFO & Treasurer Compensation: $504.14kMr. Alex C. Levit Esq. (Age 45)Chief Legal Officer & Corporate Secretary Compensation: $483.83kMr. Christopher Beck M.B.A.Senior Vice President of Operations More Insider Trading Tools from MarketBeat Related Companies UNCY Insider Selling MREO Insider Selling ARCT Insider Selling YMAB Insider Selling ZVRA Insider Selling ESPR Insider Selling RGNX Insider Selling SLRN Insider Selling MGTX Insider Selling XERS Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CNTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Context Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Context Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNTX Stock Alerts